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sured by standard procedures. In addition, 40 subjects from the cross-
sectional study groupwere prospectively followed over a 1-year period.
They found that adipose tissue preferentially accumulated in the left RS
andwas relatedwith retroperitoneal, intraperitoneal, and subcutaneous
adipose tissue measurements. Furthermore, RS adipose tissue directlyThe epidemic of obesity and overweight has been reaching unimag-
inable proportions, and is currently affecting more than 2.1 billion peo-
ple worldwide (Ng et al., 2014). Obesity is characterized by ectopic fat
accumulation, the presence of adipose tissue within tissues that under
normal conditions either do not contain or contain small amounts of ad-
ipose tissue. Importantly, accumulation of ectopic fat attributed to obe-
sity plays an important role in the development of cardiovascular and
metabolic disorders, including diabetes and hypertension (Sironi et al.,
2011).
Previous studies have shown that ectopic fat accumulation in the
renal sinus (RS) — a compartment located at the medial border of the
kidney that contains renal vessels, calices, nerve tissue, and lymphatic
channels — is associated with an increased risk of hypertension and
chronic renal disease. For example, quantiﬁcationof RS fat accumulation
in participants from the Framingham Heart Study revealed that the
amount of RS fat was independently associated with measures of
blood pressure and renal function (Foster et al., 2011). Similarly, RS fat
accumulation correlated with the number of antihypertensive drugs
and blood pressure levels after therapy in individuals at risk for cardio-
vascular events (Chughtai et al., 2010), suggesting a potential role of this
fat depot in hypertension and renal dysfunction. Alas, little is known
about the precise mechanism by which RS adipose tissue contributes
to renal injury.
In this issue of EBioMedicine, the study of Krievina et al. takes a step
in this direction by linking accumulation of adipose tissue in the RSwith
early diagnostic biomarkers of kidney injury (Krievina et al., in this
issue). In this cross-sectional study, 280 asymptomatic middle-age par-
ticipants were recruited, abdominal and RS adipose tissue wereom.2016.10.020.
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in).
. This is an open access article underquantiﬁed by computed tomography, and serum levels of kidney injury
molecule (sKIM)-1 and ﬁbroblast growth factor (FGF)-21 were mea-
correlated with the early renal injury markers sKIM-1 and FGF-21. Fol-
low up studies showed that accumulation of adipose tissue in the RS
was associated with increased visceral adipose tissue volume, whereas
reductions in visceral adipose tissue volume were not accompanied by
reductions in RS adiposity. Therefore, these observations point to an
emerging central role of RS adipose tissue in the development of obesi-
ty-induced renal damage.
Accumulating evidence indicates that KIM-1 — a transmembrane
type-1 glycoprotein expressed at very low levels in healthy tubular ep-
ithelial cells —, is a sensitive biomarker for the early prediction of renal
injury. Studies have shown that serum and urinary KIM-1 levels in-
crease after acute ischemic injury and acute ischemic events in post-is-
chemic kidneys (Sabbisetti et al., 2014; Eirin et al., 2012). Mechanical
compression of renal blood vessels and tubules due to excessive accu-
mulation of fat in the RS may trigger hypoperfusion of the renal paren-
chyma and subsequent tubular injury. In support of this notion, authors
found that sKIM-1 levels directly correlated with increments in RS adi-
pose tissue, suggesting that tubular epithelial damage secondary to RS
fat compressionmay be an importantmechanismmediating obesity-in-
duced renal damage.
Furthermore, the amount of RS adipose tissue directly correlated
with serum levels of the adipokine FGF-21, a key mediator of fatty
acid oxidation and lipid metabolism (Woo et al., 2013). Prospective
studies have shown that serum FGF-21 is an independent predictor of
kidney disease progression (Lee et al., 2015). In agreement, Krievina et
al. found that FGF-21 inversely correlated with GFR, but directly corre-
lated with the amount of RS adipose tissue, suggesting a link between
RS fat accumulation and renal dysfunction.
The use of volumetric analysis and 3D reconstruction of various ad-
ipose tissue segments to assess RS fat content is an important strength
to this study. This strategy offers important advantages over computed
tomography or magnetic resonance single-scan measurements, which
often lead to inaccurate results. In addition, authors measured RS adi-
posity in both kidneys, revealing asymmetrical RS adipose tissue accu-
mulation, possibly due to anatomic and functional differences
between the left and right kidney.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lation of adipose tissue in the RS was associated with increased visceral
adipose tissue volume, supporting their long term interaction. Contrari-
ly, reductions in the amount of visceral adipose tissue did not affect RS
adiposity, suggesting that weight loss may not correct RS fat accumula-
tion. Additional prospective studies are warranted to determine wheth-
er dietary changes inﬂuence the amount RS fat and its association with
renal dysfunction.
In summary, the results of this study suggest that RS adipose tissue
effects should be assessed primarily on the left kidney, and imply that
RS adipose tissue may be associated with an increased risk for tubular
epithelial cell damage. Taken together, these observations shed light
on the pathophysiological mechanisms underlying the contribution of
RS adiposity to renal injury. Further studies are needed to establish a
cause-effect relationship between RS adipose tissue and renal
dysfunction.
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